Sinopharm

Merck Grants Sinopharm Rights to Covid Pills

US drugs giant Merck & Co has granted Sinopharm exclusive import and distribution rights to its oral Covid treatment Lagevrio (molnupiravir) in China.

Chinese Vaccines Provoke Discussion

Marching to the tune of the groundswell generated by Western Covid-19 vaccines approved, distributed and administered in the US, UK and the EU in recent weeks, Chinese vaccine manufacturers have been beating the drum for their candidates in countries in Latin America and the Middle East as well as at home.

China to Cut Prices of More than 400 Drugs from February

Merck & Co Ties with Sinopharm to Boost China Presence